Analysts Set Expectations for AC Immune FY2024 Earnings
Research analysts at Leerink Partnrs upped their FY2024 earnings estimates for shares of AC Immune in a report issued on ...
AC Immune SA: Promising Pipeline Developments and Robust Financial Health Justify Buy Rating
Leerink Partners analyst Marc Goodman has maintained their bullish stance on ACIU stock, giving a Buy rating yesterday. Marc Goodman has given ...